The decision hands Bayer the first ever approval for a Factor XIa inhibitor, which aim to slow the activity of a protein that regulates how the body forms clots without increasing the risk of bleeding.
Source link
About The Author
Bayer Gets in China Its First Global Approval for Stroke Prevention Drug